RxDoctor Payments DataLook up a doctor →

Steven Geller, MD

Internal Medicine · Elkridge, MDNPI 1487661831

Payments from drug & device makers

$15,054,760in general payments, 2019–2025

Across 2,807 payments — averaging $5363.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$5.5M
  • Modernatx, Inc.$1.8M
  • Merck$1.3M
  • Bavarian Nordic A/s$1.2M
  • Johnson & Johnson$853K
  • GSK$726K
  • plus $3.6M from 52 others
$3,853in research payments, 2019–2025

Across 23 payments — averaging $167.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K
  • Novo Nordisk AS$1K
  • AbbVie$960

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC98$5,548,404
Modernatx, Inc.752$1,802,379
Merck109$1,320,703
Bavarian Nordic A/s73$1,158,080
Johnson & Johnson61$852,800
GSK236$726,487
Pfizer133$646,172
Abbott27$628,753
Novo Nordisk AS487$534,299
Eli Lilly17$361,389
AbbVie(2 entities)126$317,173
Seqirus USA Inc280$258,548
Gen-probe, Inc.8$258,110
OPKO Pharmaceuticals, LLC22$227,176
AstraZeneca40$76,140
Ironwood Pharmaceuticals, Inc15$65,528
Eisai Inc.28$64,818
Sanofi Pasteur Inc.10$62,255
Amgen(2 entities)13$59,297
Novartis9$42,684
Astrazeneca UK Limited2$15,898
Novo Nordisk85$15,488
Tolmar, Inc.2$9,000
Lilly USA, LLC27$472
Amarin Pharma, Inc.24$445
Boehringer Ingelheim17$286
Astellas Pharma US Inc12$234
Exact Sciences10$228
Antares Pharma, Inc.12$191
Biohaven Pharmaceutical Holding Company Ltd.7$130
Teva Pharmaceuticals USA, Inc.7$122
Kaleo, Inc.5$106
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$89
Esperion Therapeutics, Inc.6$88
Philips North America LLC4$79
Biofire Diagnostics, LLC1$74
Corcept Therapeutics3$69
Boston Scientific2$68
Genentech USA, Inc.3$53
Optinose US, Inc.3$44
Sumitomo Pharma America, Inc.2$42
Halozyme Inc2$38
Hologic Sales And Service, LLC3$36
Biohaven Pharmaceuticals, Inc.2$30
Acerus Pharmaceuticals Corporation2$28
Takeda Pharmaceuticals U.S.A., Inc.2$26
Ascensia Diabetes Care US Inc.1$26
Xeris Pharmaceuticals, Inc.1$20
Bioventus LLC1$19
Phadia US Inc.1$19
Idorsia Pharmaceuticals US Inc1$17
Mylan Specialty L.p.1$17
Endo Pharmaceuticals Inc.1$16
Medtronic1$14
Hikma Pharmaceuticals USA1$14
E.r. Squibb & Sons, L.L.C.1$13
Jazz Pharmaceuticals Inc.1$12
Kowa Pharmaceuticals America, Inc.1$12

How this compares

$15,054,760 in reported general payments places this provider in the 95th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland →

Medicare billing

Part B allowed, 2024
$726,378
Medicare patients
2,565
Services billed
16,093

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Elkridge

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →